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Research background. Depression has become a global threat to human health. In or-
der to solve it, researchers have conducted multi-faceted studies including diet. Many 
food-derived bioactive substances have shown antidepressant effects. However, there 
are few studies on the design of industrialized food with antidepressant effect. This study 
aims to evaluate the antidepressant effect of afunctional beverage made from several in-
gredients with potential antidepressant function and investigate its antidepressant mech-
anisms.
Experimental approach. The beverage consists of peppermint oil, active peptides de-
rived from bovine milk casein and Acanthopanax senticosus extract (ASE) whose active 
ingredient is eleutheroside. Different amounts of ASE were evaluated to determine the 
optimal concentration of eleutheroside in this functional beverage to deliver the best anti-
depressant effect through extensive behavioral testing, including preliminary acute stress 
experiments and further chronic unpredictable mild stress test.
Results and conclusions. The results demonstrated that the beverage with 15 mg/kg of 
eleutheroside could significantly reduce the mice’s immobility time of tail suspension test 
and forced swimming test, recover mice’s sucrose preference and behavior changes in the 
open field test, improve the contents of dopamine, norepinephrine, 5-hydroxytryptamine 
and the activity of superoxide dismutase and reduce the content of malondialdehyde in 
mice’s brains, which indicated that the improvement of monoamine neurotransmitter sys-
tems and antioxidation was one potential mechanism of antidepressant action.
Novelty and scientific contribution. This study provides a design of antidepressant func-
tional beverage and an efficient way for the prevention and treatment of depression.
Key words: functional beverage, eleutheroside, behavioral testing, antidepressant mech-
anism, monoamine, antioxidation
INTRODUCTION
Major depressive disorder (MDD) is a serious mood disorder, which can be caused 
by a combination of biological, psychological and social distress. Patients suffering from 
depression often have unstable emotions, with long-lasting symptoms that usually de-
prive the patient’s capabilities for work and logical communication (1). Depression could 
even lead to suicide. According to the World Health Organization (WHO), 850 000 people 
commit suicide every year due to depression (2). The WHO had predicted that depression 
would be one of the two top causes of global health disorders and disability (3).
In addition to common nutrients, foods are also sources of bioactive substances that 
have a potential positive impact on human health (4). Diet may provide considerable ben-
efits for moderate to severe depression and anxiety (5). According to reports, some Chi-
nese herbal medicines and fruits also have certain antidepressant effects (6-8). Mint, the 
dried aerial part of the Lamiaceae plant Mentha haplocalyx Briq., is cool-natured, with ac-
rid flavour, and it can disperse stagnated liver in the beliefs of traditional Chinese med-
icine (9). l-menthol is the main active ingredient of the mint, and its content is up to 87 
% in the essential oil of mint (10). It was able to induce an antidepressant-like effect in a 
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mouse model of depressive behavior, and this effect might 
be partially mediated by dopaminergic (DAergic), 5-hydrox-
ytryptaminergic and gamma-aminobutyric acidergic path-
ways (9). Acanthopanax senticosus Harms (ASH) root bark 
is also traditionally used to treat high blood pressure and 
mental disorders in China (11,12). ASH has an anxiolytic ef-
fect against not only mild anxiety, but also anxiety due to 
higher levels of stress, which is related to an increase in hip-
pocampal brain-derived neurotrophic factor signaling (13). 
Bioactive peptides are small protein fragments derived from 
enzymatic hydrolysis and gastrointestinal digestion of food 
proteins, which are beneficial to living beings (14). Among 
the many protein foods, milk is a major research object (15). 
Kim et al. (16) have shown that the ingestion of alpha(S1)-ca-
sein hydrolysate can decrease the stress-related symptoms 
in females, particularly in intellectual and emotional prob-
lems. Guesdon et al. (17) demonstrated that in mice the tryp-
tic bovine alpha(S1)-casein hydrolysate has protective effect 
on sleep during exposure to chronic mild stress conditions. 
In recent years, the demand for foods with additional func-
tional benefits has been increasing (18). However, the design 
of industrialized food with antidepressant effect has been 
rarely explored.
In the present study, a beverage (referred as functional 
beverage below) was designed, which consisted of pepper-
mint oil, active peptides derived from bovine milk casein and 
Acanthopanax senticosus extract (ASE) whose active ingredi-
ent is eleutheroside. In order to fully confirm antidepressant 
effect of the functional beverage in mice and determine the 
optimal concentration of eleutheroside in the functional bev-
erage to deliver the best antidepressant effect, we conduct-
ed extensive behavioral testing including preliminary acute 
stress experiments and further chronic unpredictable mild 
stress (CUMS) test. The potential antidepressant mechanisms 
were also investigated.
MATERIALS AND METHODS
Preparation of functional beverage
We chose bovine milk casein hydrolysates, peppermint 
oil (Jinxing Spice, Dongtai, Jiangsu, PR China) and Acantho-
panax senticosus extract (ASE; Hongda Plant Chemical, Xi’an, 
Shaanxi, PR China) as the ingredients of functional beverage 
and their concentration settings referred to some reports and 
a Chinese national food standard (19-21). The functional bev-
erage was made of peppermint oil (0.30 g/kg), bovine milk ca-
sein hydrolysates (690 g/kg) and ASE (0.25-2.00 g/kg), which 
contained, respectively, 0.10 g/kg menthol, 25.05 g/kg active 
peptides and 3.75-30.00 mg/kg eleutheroside, consisting of 
equal amounts of eleutheroside B and eleutheroside E.
We prepared and determined bovine milk casein hydro-
lysates in our previous study with the same enzymes and re-
agents (22). The protein content of bovine milk casein hydro-
lysates was determined to be 4.06 % (by mass) by Kjeldahl 
method (23). The trichloroacetic acid precipitation method 
(24) was used to measure the peptide mass fraction of the 
hydrolysates, which was 3.63 % (by mass). The hydroxyl rad-
ical-scavenging activity of bovine milk casein hydrolysates 
was determined to be 50.06 % by using the 2-deoxy-d-ribose 
oxidation method (22). The mass fractions of menthol in pep-
permint oil and eleutheroside in ASE were respectively 33.33 
and 1.50 %, which were obtained from the guaranteed anal-
ysis provided by the manufacturer. In the following text, all 
mass fractions refer to the mass fraction of eleutheroside in 
the functional beverage.
Animals
Male Kunming mice (20-25 g) and fodder were provided 
by the experimental animal center of Fourth Military Medi-
cal University (Xi’an, Shaanxi, PR China). The production li-
cense number of experimental animal was SCXK (Shaanxi) 
2014-002. The fodder was standard mice pellet feed. The rear-
ing environment was a specified pathogen-free laboratory 
animal room with the license number of experimental ani-
mal SYXK (Shaanxi) 2014-001. All animals were housed un-
der standard conditions of temperature (22±2) °C, humidity 
(55±4) % and light (12:12 h light/dark cycle), and free access to 
food and water. Clomipramine hydrochloride (CH; Weimeng 
Biotech, Shanghai, PR China) was used in the present study. 
All animal use procedures were carried out in accordance 
with the Regulations of Experimental Animal Administration 
issued by the State Committee of Science and Technology of 
the People’s Republic of China (25), with the approval of the 
Northwest A&F University Ethical Committee. All behavioral 
experiments were performed once.
Preliminary acute stress experiment
Treatments in acute stress experiment
Acute stress experiment in the present study included 
forced swimming test (FST) and tail suspension test (TST), 
which are used widely to measure the pharmacological ef-
fects of antidepressant drugs or changes in stress-evoked 
behavior in mice (26,27). They were carried out in order to 
determine the preliminary mass fraction with a better anti-
depressant effect. In each test, fifty experimental mice were 
randomly divided into 5 groups (N=10). They were fed with 
normal saline (control group), 40 mg/kg CH (CH group), and 
three functional beverage samples (7.50, 15.00 and 30.00 mg/
kg of eleutheroside). All animals in each group were fed twice 
a day with intragastric administration of 0.02 mL/g body mass 
every time for 5 days continuously. The mice were not anes-
thetized before gavage. Mice that were subjected to TST and 
FST were sacrificed by cervical dislocation.
Tail suspension test
The TST was conducted 1 h after the last intragastric ad-
ministration on day 5. Mice were suspended for 6 min by plac-
ing an adhesive tape 1 cm away from the tip of the tail. Each 
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mouse was suspended 50 cm away from the floor and was 
acoustically and visually isolated from other animals during 
the test. The immobility time of each mouse was subsequent-
ly recorded. Immobility was defined as when the mouse’s 
four paws and head were all immobile or passively swing-
ing (28).
Forced swimming test
The FST was conducted 1 h after the last intragastric ad-
ministration on day 5. Each mouse was placed into an 80-li-
tre polypropylene basin (height 24 cm, diameter 65 cm) filled 
with 50 L of water at (25±1) °C. The mouse was forced to swim 
for 6 min and judged to be immobile when it floated in an 
upright position and made only small movements to keep its 
head above water. The duration of immobility was recorded 
during the last 4 min of the 6-minute testing period (29). The 
FST for each mouse was conducted individually.
Further chronic unpredictable mild stress test
Treatments in chronic unpredictable mild stress test
CUMS test was carried out in order to determine the opti-
mal mass fraction of eleutheroside with the best antidepres-
sant effect. Other 60 mice were divided into six groups (N=10) 
randomly. There were normal control group, model control 
group, CH (40 mg/kg) group, and functional beverage (3.75, 
7.50 and 15.00 mg/kg of eleutheroside) groups. Note that the 
functional beverage mass fractions were adjusted in CUMS 
test based on the results of the preliminary acute stress ex-
periment. The functional beverage group (30.00 mg/kg) was 
removed and new dose group (3.75 mg/kg) was added. Mice 
in normal control group and model control group were fed 
with normal saline. All mice were fed once a day by oral gav-
age at 0.02 mL/g body mass for three weeks. The mice were 
not anesthetized before gavage.
Normal control group was not stimulated. Other mice 
were subjected to CUMS as described by Kaye et al. (30) with 
some modifications. Animals were subjected to stress para-
digm randomly once a day over a period of three weeks. The 
order of stressors is shown in Table 1. After three weeks of 
stress, an open field test and a sucrose preference test were 
conducted for each mouse.
Open field test
A 40 cm high, 80 cm long and 80 cm wide case was pre-
pared for this experiment. The case was separated into 25 equal 
areas (16 cm by 16 cm) by drawing black lines. Each mouse was 
placed at the center of the case at the beginning and allowed 
to move freely in this open field case. Within the 3-minute test, 
the time that the mouse stays in the center area, the number of 
times that the mouse moves across lines, the number of stand-
up times and the number of stools were recorded (31).
Sucrose preference test
Sucrose preference test was employed herein to deter-
mine the anhedonia, which is one of the core symptoms of 
major depression in humans (32). After chronic stress experi-
ment, each mouse was offered two bottles of water (one with 
water and the other one with water with 29.24 mM sucrose). 
This experiment began at 4:00 pm after CUMS and ended at 
8:00 am of the second day. Water and sucrose intakes were 
calculated by weighing each bottle. Then, the sucrose pref-
erence was calculated according to the following equation:
 w(sucrose preference)= 
 m(sucrose)/[m(sucrose)+m(water)]                   /1/
where m(sucrose) is the mass of sucrose water intake in mice 
and m(water) is the mass of water intake in mice.
Determination of monoamine and antioxidation
Mice after CUMS were sacrificed by cervical dislocation on 
the ice pack and their brains were isolated and weighed. Brain 
homogenates were prepared manually from normal saline and 
mice brain tissues in a ratio of 9:1 (by mass). The supernates 
were stored in a -80 °C environment after centrifugation at 
15 000×g and 4 °C for 10 min (H1650; Xiangyi Centrifuge Instru-
ments, Changsha, Hunan, PR China). Levels of dopamine (DA), 
5-hydroxytryptamine (5-HT) and norepinephrine (NE) were 
measured by enzyme-linked immunosorbent assay (ELISA) kits 
(H710, H104, H096; Jiancheng Bioengineering Institute, Nan-
jing, Jiangsu, PR China) using a microplate reader (Model 680; 
Bio-Rad Laboratories, Redmond, WA, USA). Superoxide dismu-
tase (SOD) and malondialdehyde (MDA) were determined by 
WST-1 method and thiobarbituric acid (TBA) colorimetry by kits 
(A001-3 and A003-1; Jiancheng Bioengineering Institute) using 
the above-mentioned microplate reader.
Statistical analysis
All the results are expressed as mean value±standard de-
viation (S.D.). The data were analyzed by one-way ANOVA test 
and Duncan’s test at p<0.05 and p<0.01 using the IBM SPSS 
Statistics v. 20.0 software (33).
RESULTS AND DISCUSSION
Effects of functional beverage on mouse behavior 
after preliminary acute stress experiment
The emotional despair is one of the core symptoms of 
depression and has causal relevance to committing suicide 
Table 1. The arrangement of random stress for animals
t/week
t/day
1 2 3 4 5 6 7
1 F E T O W S C
2 W O C S E T F
3 C E W F T S O
F=food deprivation for 24 h, E=exposure to empty water bottles for 
24 h, T=tail pinch (60 s), O=overnight illumination, W=exposure to 
wet caging (200 mL of water into the sawdust bedding) for 24 h, 
S=cold water swimming for 5 min at 4 °C, C=tilted cage at 45 degrees 
for 24 h
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(34). TST is a desperate model induced by the inability to over-
come abnormal postures and FST induces despair through 
the inability to escape the water environment (35,36). In ad-
dition, another symptom of depression is psychomotor re-
tardation manifested as the reduction in locomotor activity 
in rodents, also known as immobility (26). Because the main 
measures of TST and FST are the reduction of locomotor ac-
tivity and they contain a desperate environment, they are 
commonly used as rodent depression models (27).
The effect of functional beverage on the immobility time 
of TST and FST is shown in Fig. 1. The immobility time in TST 
and FST was very significantly reduced in the dose groups of 
7.50 and 15.00 mg/kg (p<0.01) as well as in the positive control 
CH group compared to the control group. The dose group of 
30.00 mg/kg had no significant difference (p>0.05) from the 
control group, which suggested that the dose of 30 mg/kg 
does not have antidepressant effect. The dose group of 7.50 
and 15.00 mg/kg in TST did not show significant difference 
(p>0.05) from the CH group, which suggested that these dose 
groups can reach the same antidepressant effect as CH group. 
These two doses (7.50 and 15.00 mg/kg) were chosen to 
be the reference doses for follow-up experiments. Since the 
highest mass fraction (30.00 mg/kg) did not have antidepres-
sant effect, it was necessary to explore the effect of lower 
mass fraction in order to obtain the most appropriate mass 
fractions of eleutheroside. Therefore, the dose group of 3.75 
mg/kg was added in the follow-up experiments.
Effects of functional beverage in mice after 
chronic unpredictable mild stress test
Effects on mouse behavior
The chronic unpredictable stress model was proposed by 
Katz et al. (37). The mice suffered a series of different stress 
stimuli including tail clip, cold-water swimming, and day- 
-night reversal within 21 days, and these stimuli were ran-
domly arranged. After the stimulation, the mice showed a se-
ries of emotional behavioral changes, such as reducing hori-
zontal activity and the ability of exploration (38). Lu et al. (39) 
demonstrated that CUMS-induced depression-like behaviors 
are coupled with DAergic hyperfunction in the nucleus ac-
cumbens and serotonergic hypofunction in the hippocam-
pus and prefrontal cortex.
The results of the open field test and the sucrose pref-
erence test are shown in Table 2. All measurements of mod-
el group were very significantly different from the control 
group (p<0.01), which proved the validity of this chronic mild 
stress model. The model control group showed significant 
differences from the CH group, the dose groups of 7.50 and 
15.00 mg/kg in sucrose preference, the number of the lattice 
moved, the stand-up times, immobility time, and the number 
of stool grains (p<0.05), except the dose group of 3.75 mg/kg 
in the stand-up times. 
Contents of dopamine, norepinephrine 
and 5-hydroxytryptamine
After accidental finding that monoamine oxidase can in-
hibit iproniazid, monoamine hypothesis of depression was 
formulated, which stated that deficiency of monoamine 
TST FST TST S.D. FST S.D.
normal control 129.53 154.61 7.49 12.9
CH 94.73 102.2 4.73 3.94
functional beverage 7.50 97.28 119.81 5.11 3.97
functional beverage 15.00 98.37 113.1 16.82 12.83





























functional beverage 7.50 functional beverage 15.00
functional beverage 30.00
Fig. 1. Effect of functional beverage on the immobility time of tail 
suspension test (TST) and forced swimming test (FST) in mice. Data 
are expressed as mean value±S.D. (N=10). Different superscripted 
lowercase letters in the same half region (TST or FST) denote signifi-
cant differences according to Duncan’s test (p<0.05). Different super-
scripted capital letters in the same half region (TST or FST) denote 
highly significant differences according to Duncan’s test (p<0.01). 
CH=clomipramine hydrochloride. Functional beverages 7.50, 15.00 
and 30.00 refer to the addition of eleutheroside in mg/kg
Table 2. Effect of the functional beverage mass fraction, expressed as eleutheroside, on the open field test and the sucrose preference test in mice
Group w(eleutheroside)/(mg/kg)
w(sucrose 
preference)/% N(lattice moved) Stand-up time t(immobility)/s N(stool grain)
Normal control (68.2±6.2)abA (91.0±5.2)bcA (24.7±3.2)abA (13.2±2.8)cCD (1.4±1.0)cB
Model control (43.0±4.4)cB (56.7±3.9)eC (10.4±3.2)cB (34.9±8.9)aA (396±1.1)aA
CH (76.0±12.8)aA (98.8±9.7)abA (26.7±2.8)aA (10.8±3.6)cD (1.1±0.7)cB
Functional 
beverage
3.75 (48.5±8.2)cB (69.7±8.6)dB (12.6±2.8)cB (22.9±4.8)bB (2.7±01.0)bAB
7.50 (66.9±8.9)abA (88.0±7.2)cA (21.9±4.4)bA (13.3±4.5)cCD (1.3±1.6)cB
15.00 (71.9±14.2)abA (100.4±7.9)aA (26.1±6.5)abA (11.0±3.4)cD (1.1±0.9)cB
Data are expressed as mean value±S.D. (N=10). Different superscripted lowercase letters in the same column denote significant differences 
according to Duncan’s test (p<0.05). Different superscripted capital letters in the same column denote highly significant differences according 
to Duncan’s test (p<0.01). CH=clomipramine hydrochloride
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neurotransmitters underlies clinical depression and depres-
sive symptoms can be alleviated by increased monoamine 
(40-42). Currently, levels of monoamine such as NE, 5-HT and 
DA are often used as indicators in antidepressant research.
The effect of functional beverage on the contents of DA, 
NE and 5-HT in mice’s brains is summarized in Table 3. Com-
pared to the normal control group, the contents of DA, NE 
and 5-HT in mice’s brains of the model control group de-
creased highly significantly (p<0.01), which denoted again 
that the mouse model of depression was established success-
fully. The contents of DA, NE and 5-HT of the dose groups of 
7.50 and 15.00 mg/kg significantly increased in comparison 
with the model group (p<0.05). The dose group of 3.75 mg/kg 
did not show significant difference (p>0.05) from the model 
control group. These results were consistent with the effects 
on sucrose preference.
Changes of superoxide dismutase activity 
and malondialdehyde content
Oxidative alterations are recognized as a critical route of 
brain damage in the pathophysiology of stress-induced psy-
chiatric disorders (43). In stress disorders, oxidative stress trig-
gers or exacerbates several routes of damage such as mito-
chondrial dysfunction, dysregulation of calcium homeostasis, 
disruption of energy pathways, damage to neuronal precur-
sors, impairment of neurogenesis and induction of signaling 
events in apoptotic cell death (44). Oxidative stress is caused 
by an imbalance between the levels of free radical production 
and efficiency of the antioxidant enzyme system to neutral-
ize and eliminate reactive oxygen species (ROS). Free-radical 
damage by ROS, such as the superoxide anion and hydrogen 
peroxide, is the primary source of oxidative stress (45). Two 
main antioxidant systems exist. The nonenzymatic system re-
lies on molecules that can directly quench ROS and the enzy-
matic system is composed of specific enzymes that detoxify 
ROS. Among the latter, the SOD family is important in oxida-
tive stress modulation (46). In addition, ROS levels are associ-
ated with lipid antioxidant defenses. The specific reduction 
in lipid-targeted antioxidant defenses may contribute to in-
creased ROS levels and oxidative damage to lipid membranes 
(lipid peroxidation) including to polyunsaturated fatty acids. 
Lipid hydroperoxide chain reactions eventually cause the for-
mation of reactive aldehydes, the end-product of lipid peroxi-
dation, as indicated by increased levels of MDA (47).
Therefore, SOD activity and MDA content in the brains of 
mice were measured to reflect oxidative alterations. Wheth-
er SOD or MDA, all the functional beverage groups were sig-
nificantly different compared with the model control group 
(p<0.05) (Table 4). The dose group of 15.00 mg/kg has the 
best effect in increasing SOD activity.
CONCLUSIONS
In conclusion, the treatment using functional beverage 
with 15.00 mg/kg eleutheroside had the best antidepressant 
Table 3. Effect of the functional beverage mass fraction, expressed as eleutheroside, on the content of dopamine (DA), norepinephrine (NE) and 
5-hydroxytryptamine (5-HT) in the brain of mice
Group w(eleutheroside)/(mg/kg) γ(DA)/(pg/mL) γ(NE)/(pg/mL) γ(5-HT)/(pg/mL)
Normal control (22.3±2.2)abAB (70.5±8.5)bcdBC (95.6±15.7)aA
Model control (16.7±2.1)dC (56.0±5.1)eD (71.4±2.9)cC
CH (23.1±2.8)aAB (86.1±9.6)aA (98.0±6.3)aA
Functional 
beverage
3.75 (18.6±1.8)cdBC (62.2±9.2)deCD (80.2±9.0)bcBC
7.50 (21.5±2.7)abcABC (73.3±8.8)bcABC (88.4±11.4)abAB
15.00 (23.8±3.9)aA (79.2±11.1)abAB (99.0±10.3)aA
Data are expressed as mean value±S.D. (N=10). Different superscripted lowercase letters in the same column denote significant differences 
according to Duncan’s test (p<0.05). Different superscripted capital letters in the same column denote highly significant differences according 
to Duncan’s test (p<0.01). CH=clomipramine hydrochloride
Table 4. Effect of functional beverage mass fraction, expressed as eleutheroside, on the content of superoxide dismutase (SOD) and malondial-
dehyde (MDA) in in protein of the mice brain
Group w(eleutheroside)/(mg/kg) Specific activity(SOD)/(U/mg)  b(MDA)/(mmol/g)
Normal control (402.6±73.2)aA (66.5±6.2)dC






Data were expressed as mean value±S.D. (N=10). Different superscripted lowercase letters in the same column denote significant differences 
according to Duncan’s test (p<0.05). Different superscripted capital letters in the same column denote highly significant differences according 
to Duncan’s test (p<0.01). CH=clomipramine hydrochloride
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effect, which significantly reduced the immobility time of 
mice in the tail suspension test and forced swimming test, 
and recovered sucrose preference degree. It also significant-
ly improved the content of dopamine, norepinephrine, 5-hy-
droxytryptamine and the activity of SOD, and decreased the 
content of MDA in mice’s brains, which indicated that the im-
provement of monoamine neurotransmitter systems and an-
tioxidation was a potential mechanism of antidepressant ac-
tion. The results implied that the functional beverage made 
of eleutheroside, active peptides and menthol may be con-
sumed by humans to achieve antidepressant effect.
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